ATC code: A07DA03
Controlled studies of differences between men and women are lacking for efficacy, safety, and pharmacokinetic properties for loperamide.
The present evidence concerning differences between men and women is limited and do not motivate differentiation in dosing or treatment.
No studies with a clinically relevant sex analysis regarding the pharmacokinetics or dosing of loperamide have been found.
No studies with a clinically relevant sex analysis regarding the effects of loperamide have been found.
No studies with a clinically relevant sex analysis regarding adverse effects of loperamide have been found.
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
Updated: 2020-08-28
Date of litterature search: 2015-06-02
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson